# A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure

> **NCT05904769** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 87 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** LIFELEAF Smartwatch

## Key facts

- **NCT ID:** NCT05904769
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-31
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-07-31
- **Target enrollment:** 87 (ACTUAL)
- **Why stopped:** Lack of staffing support
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05904769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05904769, "A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05904769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*